Intensity-modulated radiotherapy: Is xerostomia still prevalent?

Mark S. Chambers; Adam S. Garden; David Rosenthal; Anesa Ahamad; David L. Schwartz; Angel I. Blanco; K. S Clifford Chao; William H. Morrison; K. Kian Ang; Randal S. Weber

doi:10.1007/s11912-005-0039-4

Intensity-modulated radiotherapy: Is xerostomia still prevalent?

Mark S. Chambers, Adam S. Garden, David Rosenthal, Anesa Ahamad, David L. Schwartz, Angel I. Blanco, K. S Clifford Chao, William H. Morrison, K. Kian Ang, Randal S. Weber

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

Conformal radiation with intensity-modulated radiotherapy (IMRT) is a technique that potentially can minimize the dose to salivary glands and thereby decrease the incidence of xerostomia. Precise target determination and delineation is most important when using salivary gland-sparing techniques of IMRT. Reduction of xerostomia can be achieved by sparing the salivary glands on the uninvolved oral cavity and keeping the mean parotid gland dose of less than 26 to 30 Gy as a planning criterion if the treatment of disease is not compromised and parotid function preservation is desired.

Original language	English (US)
Pages (from-to)	131-136
Number of pages	6
Journal	Current oncology reports
Volume	7
Issue number	2
DOIs	https://doi.org/10.1007/s11912-005-0039-4
State	Published - Mar 2005

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s11912-005-0039-4

Cite this

@article{d5787663d71a47918181bf76c619e873,

title = "Intensity-modulated radiotherapy: Is xerostomia still prevalent?",

abstract = "Conformal radiation with intensity-modulated radiotherapy (IMRT) is a technique that potentially can minimize the dose to salivary glands and thereby decrease the incidence of xerostomia. Precise target determination and delineation is most important when using salivary gland-sparing techniques of IMRT. Reduction of xerostomia can be achieved by sparing the salivary glands on the uninvolved oral cavity and keeping the mean parotid gland dose of less than 26 to 30 Gy as a planning criterion if the treatment of disease is not compromised and parotid function preservation is desired.",

author = "Chambers, {Mark S.} and Garden, {Adam S.} and David Rosenthal and Anesa Ahamad and Schwartz, {David L.} and Blanco, {Angel I.} and Chao, {K. S Clifford} and Morrison, {William H.} and Ang, {K. Kian} and Weber, {Randal S.}",

year = "2005",

month = mar,

doi = "10.1007/s11912-005-0039-4",

language = "English (US)",

volume = "7",

pages = "131--136",

journal = "Current oncology reports",

issn = "1523-3790",

publisher = "Current Science, Inc.",

number = "2",

}

TY - JOUR

T1 - Intensity-modulated radiotherapy

T2 - Is xerostomia still prevalent?

AU - Chambers, Mark S.

AU - Garden, Adam S.

AU - Rosenthal, David

AU - Ahamad, Anesa

AU - Schwartz, David L.

AU - Blanco, Angel I.

AU - Chao, K. S Clifford

AU - Morrison, William H.

AU - Ang, K. Kian

AU - Weber, Randal S.

PY - 2005/3

Y1 - 2005/3

N2 - Conformal radiation with intensity-modulated radiotherapy (IMRT) is a technique that potentially can minimize the dose to salivary glands and thereby decrease the incidence of xerostomia. Precise target determination and delineation is most important when using salivary gland-sparing techniques of IMRT. Reduction of xerostomia can be achieved by sparing the salivary glands on the uninvolved oral cavity and keeping the mean parotid gland dose of less than 26 to 30 Gy as a planning criterion if the treatment of disease is not compromised and parotid function preservation is desired.

AB - Conformal radiation with intensity-modulated radiotherapy (IMRT) is a technique that potentially can minimize the dose to salivary glands and thereby decrease the incidence of xerostomia. Precise target determination and delineation is most important when using salivary gland-sparing techniques of IMRT. Reduction of xerostomia can be achieved by sparing the salivary glands on the uninvolved oral cavity and keeping the mean parotid gland dose of less than 26 to 30 Gy as a planning criterion if the treatment of disease is not compromised and parotid function preservation is desired.

UR - http://www.scopus.com/inward/record.url?scp=20144387508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144387508&partnerID=8YFLogxK

U2 - 10.1007/s11912-005-0039-4

DO - 10.1007/s11912-005-0039-4

M3 - Review article

C2 - 15717947

AN - SCOPUS:20144387508

SN - 1523-3790

VL - 7

SP - 131

EP - 136

JO - Current oncology reports

JF - Current oncology reports

IS - 2

ER -

Intensity-modulated radiotherapy: Is xerostomia still prevalent?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this